drugset / Trial / NCT06879158
A Study to Evaluate the Pharmacokinetics and Safety of BR3409 and Co-administration of BR3409-1 and BR3409-2 in Healthy Volunteers Under Fasting Conditions
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this clinical study is to evaluate the pharmacokinetics and safety of BR3409 and co-administration of BR3409-1 and BR3409-2 in healthy volunteers Under Fasting Conditions
Timeline
- Start
- 2024-11-10
- Primary completion
- 2025-01-26
- Completion
- 2025-01-26
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BR3409 | Unknown | — | — |
| Comparator | BR3409-1 | Unknown | — | — |
| Comparator | BR3409-2 | Unknown | — | — |